Integer Holdings EBIT per Share
The EBIT per Share of Integer Holdings (ITGR) as of Aug 20, 2026 is 5.95 USD. In the previous year, EBIT per Share was 5.75 USD — a change of 3.64% (higher).
Get this data via API
Financial Data API
EBIT per Share
5.95USD
YoY
3.64%
Last updated:
EBIT per Share of Integer Holdings is 2026 5.95 USD. EBIT per Share of Integer Holdings was 2025 5.75 USD. It decreases by 3.64% higher compared to the previous year.
Access this data via the Eulerpool API
Integer Holdings Stock analysis
What does Integer Holdings do? Integer Holdings Corp is a globally leading medical technology company that provides a wide range of products and services to customers in various fields. The company was founded in 1979 by a man named Donald M. Stelling to develop medical devices.
The company has since grown significantly and has become one of the leading providers of medical technology products. Its business model is based on providing high-quality and innovative products tailored to the needs of customers. Integer Holdings Corp is divided into four business segments.
The first segment is Medical Devices, where solutions are developed for patients and medical professionals. This includes the production of catheters, medical pumps, and precision measurement devices, which play an important role in the medical care of patients. The segment specializes in the development of customized solutions for OEM manufacturers.
The second segment is Power Solutions, where high-quality batteries, chargers, and power packs are manufactured for a wide range of medical devices. These batteries are designed for a long lifespan and ensure reliable power supply for medical devices.
In the third segment, Advanced Surgical, innovative solutions for surgery are developed, such as suction and cutting devices for minimally invasive procedures. The modern surgical instruments offer high precision and are tailored to the needs of patients, surgeons, and clinics.
The fourth and final segment is Cardio & Vascular, where products for the treatment of cardiovascular diseases are manufactured. This includes stents, balloon catheters, and pacemakers, among others. They assist doctors in monitoring and regulating the condition of patients.
Overall, the company offers a wide range of products that are essential for the medical care of patients and the work of clinic staff and medical professionals. Integer Holdings Corp is committed to meeting the needs of its customers through innovative solutions.
The company also has a strong commitment to quality and safety. It maintains strict controls and systems to ensure that all products meet the highest standards. Integer Holdings Corp is also dedicated to sustainable manufacturing and environmentally friendly disposal of medical technology.
Overall, Integer Holdings Corp is a leading provider of medical technology products, distinguished by its innovative and customer-oriented business model. With its solutions in the Medical Devices, Power Solutions, Advanced Surgical, and Cardio & Vascular segments, the company ensures that patients and medical professionals always have access to the best technologies and products to ensure successful treatment of diseases and injuries. Integer Holdings is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Integer Holdings stock
EBIT per Share of Integer Holdings is 5.95 USD in 2026.
EBIT per Share of Integer Holdings changed from 5.75 USD to 5.95 USD, representing a 3.64% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Integer Holdings since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Integer Holdings
All Key Metrics — Integer Holdings
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth